-
1 Comment
CRH Medical Corporation is currently in a long term uptrend where the price is trading 34.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.
CRH Medical Corporation's total revenue rose by 21.1% to $37M since the same quarter in the previous year.
Its net income has dropped by 1671.0% to $-19M since the same quarter in the previous year.
Finally, its free cash flow fell by 9.2% to $11M since the same quarter in the previous year.
Based on the above factors, CRH Medical Corporation gets an overall score of 3/5.
| ISIN | CA12626F1053 |
|---|---|
| CurrencyCode | USD |
| Exchange | NYSE MKT |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Target Price | 3.4 |
|---|---|
| Dividend Yield | 0.0% |
| PE Ratio | None |
| Market Cap | 282M |
| Beta | 3.11 |
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. It also offers a hemorrhoid banding ancillary program, cybersecurity, and a consumer-centric digital application. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada. As of April 22, 2021, CRH Medical Corporation operates as a subsidiary of WELL Health Technologies Corp.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CRHM using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
